Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

AI chatbots can help teach dermatology but need careful checking for accuracy.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

VGG19 is more accurate, but MobileNetV2 is faster and uses fewer resources.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Nail pitting in kids can be harmless or indicate other health issues, so thorough evaluation is crucial.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

3D high-frequency ultrasound can help diagnose skin and hair conditions without invasive biopsies.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Low-Level Laser Therapy might be an effective alternative hair loss treatment for some people.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Low-Level Laser Therapy might be a good alternative for hair loss when other treatments fail, but its effectiveness varies and more research is needed.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

A 7-year-old boy's unusual hair loss was caused by a herpes infection and healed after treatment.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Hair loss can be reversed or even cured using advanced hair restoration techniques, with rare complications like swelling and bleeding.

Portraits show women's hairlines have moved forward over time, suggesting changes in the occurrence of frontal hair loss.

Vitamin D receptor is crucial for hair health and may help treat hair loss.